Gene expression studies performed by Kuehl and colleagues showed that multiple myeloma is associated explicitly with TRAF2 and TRAF3 gene mutations that promote activation of the NFκB system via an alternative pathway [14]. This evidence concerns the gene TRAF3 and plasma cell myeloma.